Concurrent Paclitaxel and Radiotherapy After Adjuvant Doxorubicin and Cyclophosphamide for Stage 2 or 3 Breast Cancer
Clinical trial NCT04809844 · UNKNOWN
Trial details
- NCT number
- NCT04809844
- Sponsor
- Assiut University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-01
- Primary completion
- 2023-11-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.